NURO vs. VAPO, INBS, VVOS, PSTV, AVGR, TMDIF, BTCY, AFIB, STSS, and VERO
Should you be buying NeuroMetrix stock or one of its competitors? The main competitors of NeuroMetrix include Vapotherm (VAPO), Intelligent Bio Solutions (INBS), Vivos Therapeutics (VVOS), Plus Therapeutics (PSTV), Avinger (AVGR), Titan Medical (TMDIF), Biotricity (BTCY), Acutus Medical (AFIB), Sharps Technology (STSS), and Venus Concept (VERO). These companies are all part of the "surgical & medical instruments" industry.
Vapotherm (NYSE:VAPO) and NeuroMetrix (NASDAQ:NURO) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, media sentiment, dividends, profitability, community ranking and analyst recommendations.
In the previous week, Vapotherm and Vapotherm both had 1 articles in the media. NeuroMetrix's average media sentiment score of 0.48 beat Vapotherm's score of 0.00 indicating that Vapotherm is being referred to more favorably in the media.
43.1% of Vapotherm shares are held by institutional investors. Comparatively, 19.4% of NeuroMetrix shares are held by institutional investors. 15.8% of Vapotherm shares are held by insiders. Comparatively, 7.3% of NeuroMetrix shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Vapotherm has a net margin of -84.74% compared to Vapotherm's net margin of -110.64%. NeuroMetrix's return on equity of 0.00% beat Vapotherm's return on equity.
NeuroMetrix received 196 more outperform votes than Vapotherm when rated by MarketBeat users. Likewise, 62.01% of users gave NeuroMetrix an outperform vote while only 53.99% of users gave Vapotherm an outperform vote.
Vapotherm has a beta of -1.05, suggesting that its stock price is 205% less volatile than the S&P 500. Comparatively, NeuroMetrix has a beta of 2.28, suggesting that its stock price is 128% more volatile than the S&P 500.
NeuroMetrix has lower revenue, but higher earnings than Vapotherm. NeuroMetrix is trading at a lower price-to-earnings ratio than Vapotherm, indicating that it is currently the more affordable of the two stocks.
Summary
Vapotherm and NeuroMetrix tied by winning 7 of the 14 factors compared between the two stocks.
Get NeuroMetrix News Delivered to You Automatically
Sign up to receive the latest news and ratings for NURO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NURO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
NeuroMetrix Competitors List
Related Companies and Tools
